意见反馈 手机随时随地看行情
  • 公司公告

公司公告

安道麦B:关于购买董监事及高级管理人员责任保险暨关联交易的公告(英文版)2024-06-13  

       Stock Code: 000553(200553)       Stock Abbreviation: ADAMA A (B)          NO. 2024-34



                                       ADAMA Ltd.
             Announcement on the Purchase of Liability
           Insurance for Directors, Supervisors and Senior
            Executives and the Related-party Transaction

The Company and all members of the Company’s Board of Directors confirm that all
information disclosed herein is true, accurate and complete, with no false or misleading statement
or material omission.


 I.       Overview of the Related Party Transaction

          On June 12, 2024, the 3rd meeting of the 10th session of the Board of Directors of
          ADAMA Ltd. (hereinafter referred to as the “Company”) considered the Proposal on
          the Purchase of Liability Insurance for Directors, Supervisors and Senior Executives
          and the Related-party Transaction. In order to further benefit from the Syngenta
          Group synergies and obtain preferable insurance terms, the Company is contemplating
          purchasing a Directors and Officers liability insurance policy by way of adding the
          Company to the Directors and Officers liability insurance policy of Syngenta Group
          Co., Ltd. (hereinafter referred to as “SG”), which shall provide shared coverage (the
          “Transaction”). Since SG is the controlling shareholder of the Company, this
          Transaction therefore constituted a related-party transaction.

          In accordance with the provisions of the Articles of Association and relevant laws and
          regulations, all the Directors abstained from voting on this proposal, and thi s
          transaction will be submitted directly to the general meeting of shareholders for
          consideration and approval, during which SG, the related party, will abstain from
          voting. This Transaction has been reviewed by the Specialized Meeting of
          Independent Directors of the Company and approved by all independent directors.

          The Transaction does not constitute a Material Assets Restructuring as stipulated by
          the Administrative Measures on Significant Asset Restructuring of Listed Companies.

 II.      Overview of the Related Party


                                                  1
       Established in 2019, SG is registered at Unit 08 of the 30th Floor, No. 88 of Shiji
       Avenue, Shanghai Pilot Free-Trade Zone of China with Mr. LI Fanrong as its legal
       representative. It has a registered capital of RMB 11,144,544,602 and operates in
       R&D, production and sales of crop protection, seeds and crop nutrition products as
       well as modern agricultural services.

       The shareholders and shareholding proportion of SG are as follows. China National
       Agrochemical Co., Ltd holds 99.1% and Maidao Agrochemical Co., Ltd., 0.9%. The
       State-owned Assets Supervision and Administration Commission of the State Council
       (SASAC) is the actual controller of SG.

       As of December 31st, 2022, the revenue of SG was RMB 224.84489 billion, net
       income 11.40569 billion, total assets 573.10198 billion and net assets 269.39203
       billion.

       Related-party relationship: as the controlling shareholder of the Company, SG is a
       related party in accordance with Item 1, Paragraph 2 of Article 6.3.3 of the Listing
       Rules of Shenzhen Stock Exchange.

       Analysis of contract performance capability: To the best of the Company’s knowledge,
       SG has sound performance capability based on its normal production and operational
       status. After searching on “the Website of Disclosure of Enforcement Information of
       China”, it is not a debtor subject to judicial enforcement.

III.   Basic Information on the Target of the Related-party Transaction

       In order to ensure the directors, supervisors and senior executives to exercise their
       management and supervisory duties independently and effectively, and to further
       benefit from the SG synergies as well as preferable insurance terms, the Company is
       contemplating purchasing a Directors and Officers liability insurance policy by way
       of adding the Company to the Directors and Officers liability insurance policy of SG,
       which shall provide shared coverage. For details, please refer to Section V of this
       announcement “Main Contents of the Liability Insurance”.

       The Board of Directors of the Company would like to request the Shareholders'
       General Meeting to authorize the management team to handle the purchase of the
       liability insurance for directors, supervisors and senior executives (including but not
       limited to the identification of the relevant insured persons; confirmation of the


                                                2
       insurance amount, premium and its adjustment and other insurance terms; signing of
       the relevant legal documents and handling of other matters in relation to the
       application for the insurance, etc.), as well as to handle the renewal or reappointment
       of the liability insurance upon or before the expiry of the existing contract.

IV.    Pricing Basis of the Related-Party Transaction

       The Transaction is made on the principles of voluntariness, equality, mutual benefit,
       justice and fairness. The terms of the Transaction were negotiated fairly on the basis
       of market practice.

V.     Main Contents of the Liability Insurance

       1. The Proposer: ADAMA Ltd.

       2. The Insurer: Zurich General Insurance (China) Company Limited

       3. The Insured: Directors of the Board, Supervisors and Senior Executives of the
       Company and its PRC subsidiaries

       4. Limit of Liability: The insurance coverage is USD 75,000,000.

       5. Premium Expenses: USD 115,680

       6. Insurance Period: From July 1, 2024 to June 30, 2025

VI.    Purpose of the Transaction and Its Impact on the Company

       As a related-party transaction for the purchase of liability insurance for the directors,
       supervisors and senior executives, this transaction is conducive to capitalizing on the SG
       synergies and its preferable terms, safeguarding the rights and interests of the Company
       and its investors and improving the Company’s risk management system. Furthermore, it
       promotes the full exercise of the rights and performance of the duties of the directors,
       supervisors and senior executives. It will not harm the interests of the Company and all
       shareholders, nor will it affect its independence.

VII.   Status of the Different Kind of Related-party Transactions between the Company
       and SinoChem Holdings

       The related-party transactions between the Company and subsidiaries of Sinochem
       Holdings are as follows.


                                                 3
     1. The occurred related-party transactions with subsidiaries of SinoChem Holdings in
       2023 in the ordinary course of business is RMB 3,246.42million. The estimated
       related-party transaction amount in 2024 in the ordinary course of business approved
       by the 2023 annual shareholders’ meeting is RMB 4,143.71 million.

     2. Deposits of the Company and its subsidiaries in the Sinochem Finance Co., Ltd.: As
        of the date of this announcement, the balance of deposits remains RMB 372 million
        and USD 2 million, which have been approved by the 1st interim shareholders
        meeting of the Company in 2022.

     3. The 33rd meeting of the 9th session of the Board of Directors approved the Proposal
        on Credit Facility from the Related Party according to which Syngenta Group (NL)
        B.V., a subsidiary of the Company's controlling shareholder SG, shall enter into
        an additional Facility Agreement and provide an amount of USD 200 million credit
        facility in favor of Adama Fahrenheit B.V. , an indirectly wholly-owned subsidiary
        of the Company, and the transaction has been approved by the 2024 1st Interim
        Shareholders Meeting .

VIII. Independent Directors’ Prior Approval

     The Company’s Specialized Meeting of Independent Directors approved the
     Transaction and the independent directors have given approval opinions on the
     Transaction:

     The transaction can safeguard the rights and interests of the Company and the directors,
     supervisors and senior executives, promote the full exercise of rights and fulfilment of
     duties by relevant persons in charge, and improve the healthy development of the
     Company.

     Following the requirements of relevant applicable laws and regulations, this related-party
     transaction is carried out in accordance with the market-oriented principle, which will not
     affect the independence of the listed company and will not be detrimental to the interests
     of the Company and other shareholders.

     Its decision-making procedures conform to the Company Law, the Rules of Shenzhen Stock
     Exchange for the Listing of Stocks, the Articles of Association of the Company and other
     laws and regulations.

     Therefore, the independent directors agreed to submit the Transaction to the Company’s

                                              4
      shareholders’ meeting for approval.

IX.   Documents for Future Reference

      1. The resolutions of the 3rd Meeting of the 10th Session of the Board of Directors of the
         Company;

      2. The resolutions of the Specialized Meeting of Independent Directors.


      It is hereby announced.



                                                    The Board of Directors of ADAMA Ltd.

                                                                                June 13, 2024




                                               5